Akso Health Group (AHG)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 6M 12M 18M FY22: 6M FY23: 13.2M FY24: 2.4M FY25: 14.8M FY26: 13.8M FY22 FY23 FY24 FY25 FY26

Gross Profit Annual

-500K 0 500K 1M 1.5M FY22: 605.1K FY23: 1.3M FY24: 122.1K FY25: -281.5K FY26: -11.3K FY22 FY23 FY24 FY25 FY26

Operating Income Annual

-180M -120M -60M 0 60M 120M 180M FY22: -3.3M FY23: -14.3M FY24: -8.6M FY25: -166.3M FY26: -20.7M FY22 FY23 FY24 FY25 FY26

Net Income Annual

-150M -100M -50M 0 50M 100M 150M FY22: -16.9M FY23: -1.4M FY24: -9.5M FY25: -135M FY26: -18.7M FY22 FY23 FY24 FY25 FY26

Cost of Revenue Annual

0 6M 12M 18M FY22: 5.4M FY23: 11.9M FY24: 2.3M FY25: 15.1M FY26: 13.8M FY22 FY23 FY24 FY25 FY26

Operating Cash Flow Annual

-15M -10M -5M 0 5M 10M 15M FY22: -8.6M FY23: -3.3M FY24: 1.4M FY25: 1.2M FY26: -12.8M FY22 FY23 FY24 FY25 FY26

Free Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M FY19: -1.7M FY20: -58.5M FY22: -8.6M FY25: 1M FY26: -12.8M FY19 FY20 FY22 FY25 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 800M 1.6B 2.4B FY22: 59.6M FY23: 68.6M FY24: 141.5M FY25: 855.3M FY26: 2.2B FY22 FY23 FY24 FY25 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.